E. coli is one of the most popular bacteria that invades and affects humans negatively. This bacteria focuses on the digestive tract of humans and attacks it viciously. The bacteria is usually known to be obtained from unclean food that allows the bacteria to enter the human body. Different symptoms from the bacteria include fever, digestive pain, diarrhea, and other complications if not treated well.
A recent study conducted by a team of researchers from the University of Birmingham was curious to know how E. coli clones can take over the human digestive tract easily and rapidly. This E. coli clone is known as a superbug which is a developed E. Coli bacteria that have made the bacteria very dominant; resisting antibacterial medications.
However, the same superbug is also fighting other E. Coli bacteria that haven’t evolved and wiping them from the human body. The study was focused on the evolved bacteria called ST131 which have caused an increase in the total number of people affected by E. Colie to 27% in 5 years.
Lead author of the study is a doctor from the University of Birmingham’s Institute of Microbiology and Infection called Dr. Alan McNally. He commented on the obtained results saying, “The most globally dominant clone of E. coli that is resistant to multiple drugs is called ST131. Earlier research has shown that while ST131 emerged and rapidly spread in the late 1990s, it caused no more than 20% of clinical cases of E. coli once it had emerged on the scene.”